Study reveals insights on hidden sexual-arousal disorder. Study reveals insights on hidden sexual-arousal disorder. Key Takeaways • Persistent genital arousal disorder is characterized by spontaneous and unwanted sexual arousal unrelated to desire
Amylyx Pharmaceuticals Announces AMX0035 Demonstrated Statistically Significant Treatment Benefit for People with ALS in the CENTAUR Trial
mylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, and the Sean M. Healey & AMG Center for ALS at Mass General today announced that AMX0035 demonstrated a significant treatment benefit for people with ALS in the CENTAUR study.
Highlights from the meeting included a robust discussion moderated by Dr. Robert Brown with guest speakers Drs. Jean-Pierre Julien, from Laval Universities Department of Psychiatry and Neuroscience, Saud Sadiq, Director and Chief Research Scientist from Tisch MS Research Center of New York and Laura Paulsen, from EnClear Therapies, who spoke on the role of CSF toxicity in ALS pathophysiology.
Inaugural Mass General Hospital HEALEY Center International Prize for Innovation in ALS Awarded at 2019 MND Meeting in Perth, Australia
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) awarded the inaugural annual Healey Center International Prize for Innovation in amyotrophic lateral sclerosis (ALS) to the team that brought to trial the first antisense oligonucleotide (ASO) therapy for ALS. Team members include researchers from academia and industry.
Study finds improving blood vessel health in the brain may help combat Alzheimer's disease. Study finds improving blood vessel health in the brain may help combat Alzheimer's disease. Key Takeaways • In patients with Alzheimer’s disease,
Congratulations to Merit Cudkowicz, MD, MSc, Director of the Sean M. Healey and AMG Center for ALS and Chief of Neurology at Mass General, who presented “A Powerful Promise,” a keynote speech at Accelerating Transformation, the 2019 Press Ganey National Client & Executive Leadership Conference in Orlando, Florida on Tuesday, November 18th.
Research Roundup November 2019. Research Roundup November 2019. Genetic study points to new strategies to delay the onset of Alzheimer’s disease Some people who carry gene mutations known to cause early onset Alzheimer’s disease do not show
Gene variant may help protect against Alzheimers disease. Gene variant may help protect against Alzheimers disease. BOSTON—A new study led by investigators at Massachusetts General Hospital (MGH), in collaboration with the University of Antioquia,
The award for scientific achievement was given to Dr. Rudolph Tanzi, the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School.
Dr. Growdon presented a series of studies examining why patients with Parkinson disease often have both motor symptoms and cognitive problems, often progressing to a full dementia. Over a decade of studies show that there is a remarkable convergence of disease pathologies overlapping classical Alzheimer disease changes with Parkinson’s disease as well.
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.